Observation on enhanced avidity on somatostatin receptor targeted 68Ga-DOTATATE PET-CT following therapy with everolimus and capecitabine-temozolamide: Is redifferentiation akin phenomenon a reality in neuroendocrine tumors?

No Thumbnail Available

Click here to download

0984.htm (3.3 KB)

Date

2016

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Description

Keywords

somatostatin receptor, 68Ga-DOTATATE PET-CT, everolimus and capecitabine-temozolamide, redifferentiation akin phenomenon, neuroendocrine tumors

Source

Nuclear Medicine Communications, 2016. Vol. 37 (6): pp. 669-671

URI

http://hdl.handle.net/123456789/14309

Collections

2016